{
  "id": 1584,
  "text": "1162,a</td><td>2007 2007</td><td>145 33</td><td>Mitomycin-C/irinotecan</td><td>85.7</td><td>5-year: 69</td><td> 5-year: 72</td></tr><tr><td>Choi et al.1164.a</td><td>2006</td><td>94</td><td>Cisplatin/ 5 fluorouracil</td><td>66</td><td> 5-year: 71</td><td>5-year: 76.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 1162,a</td><td>2007 2007</td><td>145 33</td><td>Mitomycin-C/irinotecan</td><td>85.7</td><td>5-year: 69</td><td> 5-year: 72</td></tr><tr><td>Choi et al.1164.a</td><td>2006</td><td>94</td><td>Cisplatin/ 5 fluorouracil</td><td>66</td><td> 5-year: 71</td><td>5-year: 76.\n\n<question>: ",
  "ChatGPT_response_0": "根据研究结果显示，使用Mitomycin-C/irinotecan化疗药物的患者5年生存率较高，为85.7％，相较于使用Cisplatin/ 5 fluorouracil化疗药物的患者效果更好。Mitomycin-C/irinotecan化疗药物的5年生存率为69％至72％，而Cisplatin/ 5 fluorouracil化疗药物的5年生存率为66％至76％。这表明前者在提高患者生存率方面具有更好的效果。",
  "query": "这项研究中发现了哪种化疗药物的5年生存率更高？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 这项研究中发现了哪种化疗药物的5年生存率更高？\n\n<reference text>: 1162,a</td><td>2007 2007</td><td>145 33</td><td>Mitomycin-C/irinotecan</td><td>85.7</td><td>5-year: 69</td><td> 5-year: 72</td></tr><tr><td>Choi et al.1164.a</td><td>2006</td><td>94</td><td>Cisplatin/ 5 fluorouracil</td><td>66</td><td> 5-year: 71</td><td>5-year: 76.\n\n<reply>: ",
  "response": "根据研究结果显示，使用Mitomycin-C/irinotecan化疗药物的患者5年生存率较高，为85.7％，相较于使用Cisplatin/ 5 fluorouracil化疗药物的患者效果更好。Mitomycin-C/irinotecan化疗药物的5年生存率为69％至72％，而Cisplatin/ 5 fluorouracil化疗药物的5年生存率为66％至76％。这表明前者在提高患者生存率方面具有更好的效果。"
}